Disease area studied	Abbreviated title	Phase	Study ID	Registry database	Study results	Plain language summary	Publication (if available)
Multiple Sclerosis	Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323	Phase 2	C32322 Terminated	NCT00484536 2006-002204-33	LINK		Polman, C. et al. Neurology;3-2-2010;74;9 Suppl. 2;A293 62nd Annual Meeting of the American Academy of Neurology (AAN), April 10-17, 2010;Toronto, Canada
Multiple Sclerosis	CDP323 Biomarker Study	Phase 2	C32325 Completed	NCT00726648			Wolf et al. PLoS ONE;2013;8;3;e58438.

Our Company

Disease Areas